Company News

Company News Corporate Media Center Events and Announcements Corporate Environment

10-282024

Nanjing Vcare Won the "Best Ecological Partner" Award from Lunan Pharmaceutical

From October 24th to 25th, the 1st Ecological Partner Conference of Lunan Pharmaceutical Gro

Learn More

11-292024
The Production Base of Nanjing Vcare, Tianshu Pharmaceutical, Successfully Passed the "Integration of Three Standards" Management System Certification

Recently, Hubei Tianshu Pharmaceutical Co., Lt...
Learn More
10-282024
Nanjing Vcare Won the "Best Ecological Partner" Award from Lunan Pharmaceutical

From October 24th to 25th, the 1st Eco...
Learn More
08-152024
The Production Base of Nanjing Vcare , Tianshu Pharmaceutical, Obtained Two Active Pharmaceutical Ingredient (API) Registration Numbers for the First Time

Recently, Hubei Tianshu Pharmaceutical Co., Lt...
Learn More
08-012024
A Delegation Led by the Global Vice President of Thermo Fisher Scientific Visited Nanjing Vcare

On August 1st, Nicky Burbidge, the Gl...
Learn More
07-222024
Nanjing Vcare Was Certified as the "Nanjing Engineering Technology Research Center in 2024"

Recently, the Nanjing Municipal Science and Te...
Learn More
07-082024
Nanjing Vcare Won the Title of "Top 20 Chinese Pharmaceutical CRO Enterprises" Again

On July 4th, the 2024 International Pharmaceut...
Learn More
06-252024
Nanjing Vcare Made a Splendid Appearance at CPHI China 2024

From June 19th to 21st, 2024, the 22nd...
Learn More
05-302024
The Application for Clinical Trial of a Class 1 New Drug Developed by Nanjing Vcare to Assist its CDMO Partners has been Officially Accepted

Recently, the application for clinical trial o...
Learn More
04-182024
PhaseⅠ Project of Tianshu Pharmaceutical, the Production Base of Nanjing Vcare, Successfully Passed the Completion Acceptance

In the first ten days of April 2024, the first...
Learn More
01-082024
Tianshu Pharmaceutical, the Production Base of Nanjing Vcare, Was Approved for the "Drug Production License", Adding a New Engine to the Whole-Industrial-Chain Layout

Recently, Hubei Tianshu Pharmaceutical...
Learn More
12-272023
Nanjing Vcare Successfully Passed the Recognition of "High-tech Enterprise"

In late December 2023, the Office of the Natio...
Learn More
07-172023
PhaseⅠ Project of Tianshu Pharmaceutical, the Production Base of Nanjing Vcare, Entered the Trial Production Stage

On July 13, 2023, Hubei Tianshu Pharmaceutical...
Learn More
07-142023
Wang Qiyang, Member of the Standing Committee of the Hubei Provincial Committee and Secretary of the Xiangyang Municipal Party Committee, Visited the Production Base of Nanjing Vcare for Inspection

On the morning of July 13th, accompani...
Learn More
06-272023
Nanjing Vcare Made an Appearance at CPHI China 2023

From June 19th to 21st, 2023, the 21st...
Learn More
06-262023
Nanjing Vcare Won the 10th Place in the "Top 20 Chinese Pharmaceutical CRO Enterprises in 2023"

Keep going with determination and reach far, ...
Learn More
04-172023
Nanjing Vcare Was Successfully Selected as an "Innovative Small and Medium-sized Enterprise in Nanjing"

Recently, the Nanjing Municipal Bureau of Indu...
Learn More
12-302022
Nanjing Vcare Helps Nanjing Chiatai Tianqing's Anti-tumor New Drug CXA03 to Obtain the Clinical Approval

Recently, CXA03, a Class 1 anti-tumor new drug...
Learn More
12-272022
Nanjing Vcare Assisted Lizhu Pharmaceutical to Obtain the Production Approval Letter of Pantoprazole Sodium for Injection

Recently, the production approval letter of pa...
Learn More
12-122022
Nanjing Vcare Ranked 10th on the "Top 20 Chinese Pharmaceutical CRO Enterprises in 2022"

On December 9, 2022, the 2022 High-Quality Dev...
Learn More
12-092022
Nanjing Vcare Obtained the First One - Time Drug Import Approval in Jiangbei New Area after Empowerment by Jiangsu Provincial Market Supervision Bureau

On December 8, 2022, Nanjing Vcare was approve...
Learn More

1 2 下一页

EN/中文

About Us

Services & Solutions

Product Center

Enterprise Panorama

Enabling Technologies

Links：Vcarepharmatech

Chemistry+Pharmacy+Medicine One-stop CRO/CDMO service platform

Join Us

Contact Us

Follow Us

Company News

Nanjing Vcare Won the "Best Ecological Partner" Award from Lunan Pharmaceutical

The Production Base of Nanjing Vcare, Tianshu Pharmaceutical, Successfully Passed the "Integration of Three Standards" Management System Certification

Nanjing Vcare Won the "Best Ecological Partner" Award from Lunan Pharmaceutical

The Production Base of Nanjing Vcare , Tianshu Pharmaceutical, Obtained Two Active Pharmaceutical Ingredient (API) Registration Numbers for the First Time

A Delegation Led by the Global Vice President of Thermo Fisher Scientific Visited Nanjing Vcare

Nanjing Vcare Was Certified as the "Nanjing Engineering Technology Research Center in 2024"

Nanjing Vcare Won the Title of "Top 20 Chinese Pharmaceutical CRO Enterprises" Again

Nanjing Vcare Made a Splendid Appearance at CPHI China 2024

The Application for Clinical Trial of a Class 1 New Drug Developed by Nanjing Vcare to Assist its CDMO Partners has been Officially Accepted

PhaseⅠ Project of Tianshu Pharmaceutical, the Production Base of Nanjing Vcare, Successfully Passed the Completion Acceptance

Tianshu Pharmaceutical, the Production Base of Nanjing Vcare, Was Approved for the "Drug Production License", Adding a New Engine to the Whole-Industrial-Chain Layout

Nanjing Vcare Successfully Passed the Recognition of "High-tech Enterprise"

PhaseⅠ Project of Tianshu Pharmaceutical, the Production Base of Nanjing Vcare, Entered the Trial Production Stage

Wang Qiyang, Member of the Standing Committee of the Hubei Provincial Committee and Secretary of the Xiangyang Municipal Party Committee, Visited the Production Base of Nanjing Vcare for Inspection

Nanjing Vcare Made an Appearance at CPHI China 2023

Nanjing Vcare Won the 10th Place in the "Top 20 Chinese Pharmaceutical CRO Enterprises in 2023"

Nanjing Vcare Was Successfully Selected as an "Innovative Small and Medium-sized Enterprise in Nanjing"

Nanjing Vcare Helps Nanjing Chiatai Tianqing's Anti-tumor New Drug CXA03 to Obtain the Clinical Approval

Nanjing Vcare Assisted Lizhu Pharmaceutical to Obtain the Production Approval Letter of Pantoprazole Sodium for Injection

Nanjing Vcare Ranked 10th on the "Top 20 Chinese Pharmaceutical CRO Enterprises in 2022"

Nanjing Vcare Obtained the First One - Time Drug Import Approval in Jiangbei New Area after Empowerment by Jiangsu Provincial Market Supervision Bureau

Chemistry+Pharmacy+Medicine
One-stop CRO/CDMO service platform

Follow Us

Contact Us